ES461100A2 - Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina. - Google Patents

Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.

Info

Publication number
ES461100A2
ES461100A2 ES461100A ES461100A ES461100A2 ES 461100 A2 ES461100 A2 ES 461100A2 ES 461100 A ES461100 A ES 461100A ES 461100 A ES461100 A ES 461100A ES 461100 A2 ES461100 A2 ES 461100A2
Authority
ES
Spain
Prior art keywords
procedure
optionally substituted
formula
lower alkyl
histamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461100A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES461100A2 publication Critical patent/ES461100A2/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Mejoras introducidas en el objeto de la patente principal nº 434.542 por procedimiento para preparar compuestos antagonistas de receptores H-2 de histamina, de fórmula 1 : **fórmula** en la que X3 y X4 , que pueden ser iguales o diferentes, son cada uno azufre, CHNO2 o NY en donde Y es hidrógeno, hidroxi, alquilo inferior, ciano o CONH, R3 y R4 que pueden ser iguales o diferentes son cada uno una agrupación de fórmula 3: Het-(CH2)mZ(CH2)n en la que Het es un anillo 2- o 4-imidazolilo opcionalmente sustituido por alquilo inferior (preferiblemente metilo), halógeno (preferiblemente cloro o bromo), trifluormetilo o hidroximetilo; un anillo 2- piridilo opcionalmente sustituido por alquilo inferior ( con preferencia metilo), halógeno (con preferencia cloro o bromo), amino, hidroxi o alcoxi inferior (con preferencia metoxi), un anillo 2-tiazolilo; un anillo 3-isotiazolilo opcionalmente sustituido por cloro o amino; Z es azufre o un grupo metileno.
ES461100A 1976-07-28 1977-07-28 Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina. Expired ES461100A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
ES461100A2 true ES461100A2 (es) 1978-12-01

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461100A Expired ES461100A2 (es) 1976-07-28 1977-07-28 Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.

Country Status (15)

Country Link
JP (1) JPS5315370A (es)
AU (1) AU2734677A (es)
BE (1) BE857218A (es)
CA (1) CA1070315A (es)
DE (1) DE2733953A1 (es)
DK (1) DK331877A (es)
ES (1) ES461100A2 (es)
FI (1) FI772293A7 (es)
FR (1) FR2359840A1 (es)
IL (1) IL52544A0 (es)
LU (1) LU77845A1 (es)
NL (1) NL7708375A (es)
NO (1) NO772668L (es)
PL (1) PL107847B1 (es)
ZA (1) ZA774552B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Also Published As

Publication number Publication date
BE857218A (fr) 1978-01-27
JPS5315370A (en) 1978-02-13
NO772668L (no) 1978-01-31
PL107847B1 (pl) 1980-03-31
CA1070315A (en) 1980-01-22
FI772293A7 (es) 1978-01-29
ZA774552B (en) 1978-06-28
DE2733953A1 (de) 1978-02-02
FR2359840A1 (fr) 1978-02-24
NL7708375A (nl) 1978-01-31
IL52544A0 (en) 1977-10-31
AU2734677A (en) 1979-02-01
DK331877A (da) 1978-01-29
PL199908A1 (pl) 1978-11-20
LU77845A1 (es) 1977-10-25

Similar Documents

Publication Publication Date Title
AR015935A1 (es) Derivados de n-aroilfenilalanina, procedimiento para su preparacion, su uso en la elaboracion de un medicamento, medicamento que los contiene y procedimiento para su preparacion.
CO4970747A1 (es) Antagonistas de receptores de il-8
PE20020272A1 (es) N-oxidos de derivados de 4-fenil-piridina como prodrogas de los antagonistas del receptor de neuroquinina 1 (nk-1)
AR029614A1 (es) Derivados de 4-fenil-piridina, su uso, un proceso para prepararlos, y medicamentos que los contienen
BR0008494A (pt) Derivados de 3-fenilpiridina e seu uso como antagonista do receptor de nk-1
DK40777A (da) Cementblanding og fremgangsmade til cementering af olieborehuller
DK0984966T3 (da) 9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer
CO5060482A1 (es) Derivados terapeuticos de biarilo
BG43007A3 (en) Method for preparing n- (bicyclo- hetero- cyclyl)- 4- piperidinamines
PT1278728E (pt) Derivados de pirrolidina e de piperidina e sua utilizacao no tratamento de disturbios neurodegenerativos
NO900336D0 (no) Fremgangsmaate til fremstilling av heterocykliske forbindelser.
NO952208L (no) Amin-derivater
ATE35506T1 (de) Selektive methode zum blockieren von 5ht2 rezeptoren.
ES2038766T3 (es) 4-aril-5-carbamoil-1,4-dihidropiridinas.
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
GR1001407B (el) Υποκατεστημένες ισοξαζολιδίνες και ισοξαζολίνες.
ES461100A2 (es) Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
FI954965A0 (fi) AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään
MX9300312A (es) Antagonistas benzopiranicos y relacionado de ltb.
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
MX9300602A (es) Analogos de fenilalanina de bombesina.
DK234282A (da) Fremgangsmaade til fremstilling af 1-(3-halogen-2-pyridinyl)piperizin
NO932390L (no) Antagonist-II-reseptorantagonister for behandling og profylakse av koronare hjertesykdommer